{"DataElement":{"publicId":"3225684","version":"1","preferredName":"Gynecologic Tumor Grouping Cervical Endometrial FIGO 2009 Stage","preferredDefinition":"The extent of a cervical or endometrial cancer within the body, especially whether the disease has spread from the original site to other parts of the body, as described by the International Federation of Gynecology and Obstetrics (FIGO) stages.","longName":"2190067v1.0:3225662v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2190067","version":"1","preferredName":"Gynecologic Tumor Grouping","preferredDefinition":"information related to gynecologic tumor grouping.","longName":"GYN_TUMOR_GP","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206690","version":"1","preferredName":"Gynecologic Neoplasm","preferredDefinition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C28016:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gynecologic","conceptCode":"C28016","definition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0016-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177523","version":"1","preferredName":"Grouping","preferredDefinition":"Grouping; a system for classifying things into groups; the activity of putting things together in groups.","longName":"Grouping","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Grouping","conceptCode":"C25523","definition":"A system for classifying things into groups or the activity of putting things together in groups.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5204-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E67FFEA3-D68C-2C1F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3225662","version":"1","preferredName":"Gynecologic Tumor FIGO 2009 Stage","preferredDefinition":"The extent of a cervical or endometrial cancer within the body especially whether the disease has spread from the original site to other parts of the body.","longName":"3225662v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage IVB","valueDescription":"FIGO Stage IVB","ValueMeaning":{"publicId":"3225663","version":"1","preferredName":"FIGO Stage IVB","longName":"3225663","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer with distant metastases, including peritoneal involvement, involvement of the supraclavicular or mediastinal lymph nodes, and metastases to the lung, bone, or liver; for endometrial cancer, it refers to cancer with distant metastases, including metastases to the inguinal lymph nodes, intraperitoneal involvement, or metastases to the lung, bone, or liver.  Endometrial cancer metastases to the para-aortic lymph nodes, vagina, adnexa, or pelvic serosa are excluded from this stage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IVB","conceptCode":"C96263","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer with distant metastases, including peritoneal involvement, involvement of the supraclavicular or mediastinal lymph nodes, and metastases to the lung, bone, or liver; for endometrial cancer, it refers to cancer with distant metastases, including metastases to the inguinal lymph nodes, intraperitoneal involvement, or metastases to the lung, bone, or liver.  Endometrial cancer metastases to the para-aortic lymph nodes, vagina, adnexa, or pelvic serosa are excluded from this stage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4ED4-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-4EED-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IVA","valueDescription":"FIGO Stage IVA","ValueMeaning":{"publicId":"3225664","version":"1","preferredName":"FIGO Stage IVA","longName":"3225664","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades the mucosa of bladder or rectum, and/or extends beyond the true pelvis; for endometrial cancer, it refers to cancer that invades the bladder mucosa and/or the bowel mucosa.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IVA","conceptCode":"C96262","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades the mucosa of bladder or rectum, and/or extends beyond the true pelvis; for endometrial cancer, it refers to cancer that invades the bladder mucosa and/or the bowel mucosa.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4EF9-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-4F12-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IV","valueDescription":"FIGO Stage IV","ValueMeaning":{"publicId":"3225665","version":"1","preferredName":"FIGO Stage IV","longName":"3225665","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades the mucosa of bladder or rectum, and/or extends beyond the true pelvis (FIGO stage IVA), or to cancer with distant metastases (FIGO stage IVB); for endometrial cancer, it refers to cancer that invades the bladder mucosa and/or the bowel mucosa (FIGO stage IVA), or to cancer with distant metastases (FIGO stage IVB).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IV","conceptCode":"C96261","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades the mucosa of bladder or rectum, and/or extends beyond the true pelvis (FIGO stage IVA), or to cancer with distant metastases (FIGO stage IVB); for endometrial cancer, it refers to cancer that invades the bladder mucosa and/or the bowel mucosa (FIGO stage IVA), or to cancer with distant metastases (FIGO stage IVB).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4F1E-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-4F37-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IIIC2","valueDescription":"FIGO Stage IIIC2","ValueMeaning":{"publicId":"3225666","version":"1","preferredName":"FIGO Stage IIIC2","longName":"3225666","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  There is no FIGO stage IIIC2 for cervical cancer; for endometrial cancer, it refers to regional metastasis to para-aortic lymph nodes with or without metastasis to pelvic lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIC2","conceptCode":"C96260","definition":"A FIGO stage term that applies to gynecologic cancers.  There is no FIGO stage IIIC2 for cervical cancer; for endometrial cancer, it refers to regional metastasis to para-aortic lymph nodes with or without metastasis to pelvic lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4F43-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-4F5C-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IIIC1","valueDescription":"FIGO Stage IIIC1","ValueMeaning":{"publicId":"3225667","version":"1","preferredName":"FIGO Stage IIIC1","longName":"3225667","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  There is no FIGO stage IIIC1 for cervical cancer; for endometrial cancer, it refers to regional metastasis to pelvic lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIC1","conceptCode":"C96259","definition":"A FIGO stage term that applies to gynecologic cancers.  There is no FIGO stage IIIC1 for cervical cancer; for endometrial cancer, it refers to regional metastasis to pelvic lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4F68-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-4F81-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IIIC","valueDescription":"FIGO Stage IIIC","ValueMeaning":{"publicId":"3225668","version":"1","preferredName":"FIGO Stage IIIC","longName":"3225668","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  There is no FIGO stage IIIC for cervical cancer; for endometrial cancer, FIGO stage IIIC is subdivided into stages IIIC1 and IIIC2; in FIGO stage IIIC1, there is regional metastasis to pelvic lymph nodes; for FIGO stage IIIC2, there is regional metastasis to para-aortic lymph nodes with or without metastasis to pelvic lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIC","conceptCode":"C96258","definition":"A FIGO stage term that applies to gynecologic cancers.  There is no FIGO stage IIIC for cervical cancer; for endometrial cancer, FIGO stage IIIC is subdivided into stages IIIC1 and IIIC2; in FIGO stage IIIC1, there is regional metastasis to pelvic lymph nodes; for FIGO stage IIIC2, there is regional metastasis to para-aortic lymph nodes with or without metastasis to pelvic lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4F8D-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-4FA6-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IIIB","valueDescription":"FIGO Stage IIIB","ValueMeaning":{"publicId":"3225669","version":"1","preferredName":"FIGO Stage IIIB","longName":"3225669","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that extends to the pelvic wall, and/or causes hydronephrosis or non-functioning kidney; for endometrial cancer, it refers to cancer with vaginal or parametrial involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIB","conceptCode":"C96257","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that extends to the pelvic wall, and/or causes hydronephrosis or non-functioning kidney; for endometrial cancer, it refers to cancer with vaginal or parametrial involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4FB2-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-4FCB-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IIIA","valueDescription":"FIGO Stage IIIA","ValueMeaning":{"publicId":"3225670","version":"1","preferredName":"FIGO Stage IIIA","longName":"3225670","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that involves the lower third of vagina and there is no extension to the pelvic wall; for endometrial cancer, it refers to cancer with involvement of the serosa and/or the adnexa.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIA","conceptCode":"C96256","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that involves the lower third of vagina and there is no extension to the pelvic wall; for endometrial cancer, it refers to cancer with involvement of the serosa and/or the adnexa.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4FD7-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-4FF0-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage III","valueDescription":"FIGO Stage III","ValueMeaning":{"publicId":"3225671","version":"1","preferredName":"FIGO Stage III","longName":"3225671","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that extends to the pelvic wall, and/or involves the lower third of vagina, and/or causes hydronephrosis or non-functioning kidney; for endometrial cancer, FIGO stage III is subdivided into stages IIIA and IIIB; in FIGO stage IIIA, there is involvement of the serosa and/or the adnexa; for FIGO stage IIIB, there is vaginal or parametrial involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage III","conceptCode":"C96255","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that extends to the pelvic wall, and/or involves the lower third of vagina, and/or causes hydronephrosis or non-functioning kidney; for endometrial cancer, FIGO stage III is subdivided into stages IIIA and IIIB; in FIGO stage IIIA, there is involvement of the serosa and/or the adnexa; for FIGO stage IIIB, there is vaginal or parametrial involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4FFC-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-5015-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IIB","valueDescription":"FIGO Stage IIB","ValueMeaning":{"publicId":"3225672","version":"1","preferredName":"FIGO Stage IIB","longName":"3225672","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades beyond the cervix, but not to the pelvic wall or lower third of the vagina and there is parametrial invasion; for endometrial cancer, in the older FIGO classification stage scheme, it referred to cervical stromal invasion.  Stage IIB for endometrial cancer has been eliminated in the most recent (2010) FIGO classification stage scheme.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIB","conceptCode":"C96254","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades beyond the cervix, but not to the pelvic wall or lower third of the vagina and there is parametrial invasion; for endometrial cancer, in the older FIGO classification stage scheme, it referred to cervical stromal invasion.  Stage IIB for endometrial cancer has been eliminated in the most recent (2010) FIGO classification stage scheme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-5021-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-503A-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IIA","valueDescription":"FIGO Stage IIA","ValueMeaning":{"publicId":"3225673","version":"1","preferredName":"FIGO Stage IIA","longName":"3225673","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades beyond the cervix, but not to the pelvic wall or lower third of the vagina and there is no parametrial invasion; for endometrial cancer, in the older FIGO classification stage scheme, it referred to endocervical glandular involvement only.  Stage IIA for endometrial cancer has been eliminated in the most recent (2010) FIGO classification stage scheme.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIA","conceptCode":"C96253","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades beyond the cervix, but not to the pelvic wall or lower third of the vagina and there is no parametrial invasion; for endometrial cancer, in the older FIGO classification stage scheme, it referred to endocervical glandular involvement only.  Stage IIA for endometrial cancer has been eliminated in the most recent (2010) FIGO classification stage scheme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-5046-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-505F-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage II","valueDescription":"FIGO Stage II","ValueMeaning":{"publicId":"3225674","version":"1","preferredName":"FIGO Stage II","longName":"3225674","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades beyond the cervix, but not to the pelvic wall or lower third of the vagina; for endometrial cancer, it refers to cancer that invades the stromal connective tissue of the cervix, but it does not extend beyond the uterus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage II","conceptCode":"C96252","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades beyond the cervix, but not to the pelvic wall or lower third of the vagina; for endometrial cancer, it refers to cancer that invades the stromal connective tissue of the cervix, but it does not extend beyond the uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-506B-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-5084-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IC","valueDescription":"FIGO Stage IC","ValueMeaning":{"publicId":"3225675","version":"1","preferredName":"FIGO Stage IC","longName":"3225675","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, there is no FIGO stage IC; for endometrial cancer, in the older FIGO classification stage scheme, it referred to invasion of more than a half of the myometrium.  Stage IC for endometrial cancer has been eliminated in the most recent (2010) FIGO classification stage scheme.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IC","conceptCode":"C96251","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, there is no FIGO stage IC; for endometrial cancer, in the older FIGO classification stage scheme, it referred to invasion of more than a half of the myometrium.  Stage IC for endometrial cancer has been eliminated in the most recent (2010) FIGO classification stage scheme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-5090-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-50A9-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IB2","valueDescription":"FIGO Stage IB2","ValueMeaning":{"publicId":"3225676","version":"1","preferredName":"FIGO Stage IB2","longName":"3225676","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to clinically visible lesions that measure more than 4.0 cm in diameter; there is no FIGO stage IB2 for endometrial cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IB2","conceptCode":"C96250","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to clinically visible lesions that measure more than 4.0 cm in diameter; there is no FIGO stage IB2 for endometrial cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-50B5-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-50CE-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IB1","valueDescription":"FIGO Stage IB1","ValueMeaning":{"publicId":"3225677","version":"1","preferredName":"FIGO Stage IB1","longName":"3225677","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to clinically visible lesions that measure 4.0 cm or less in diameter; there is no FIGO stage IB1 for endometrial cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IB1","conceptCode":"C96249","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to clinically visible lesions that measure 4.0 cm or less in diameter; there is no FIGO stage IB1 for endometrial cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-50DA-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-50F3-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IB","valueDescription":"FIGO Stage IB","ValueMeaning":{"publicId":"3225678","version":"1","preferredName":"FIGO Stage IB","longName":"3225678","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is clinically visible and is confined to the cervix or it is diagnosed microscopically and the stromal invasion is more than 5.00 mm and the horizontal spread is more than 7.00 mm; for endometrial cancer, it refers to cancer that is confined to the uterine body and invades one-half or more of the myometrium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IB","conceptCode":"C96248","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is clinically visible and is confined to the cervix or it is diagnosed microscopically and the stromal invasion is more than 5.00 mm and the horizontal spread is more than 7.00 mm; for endometrial cancer, it refers to cancer that is confined to the uterine body and invades one-half or more of the myometrium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-50FF-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-5118-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IA2","valueDescription":"FIGO Stage IA2","ValueMeaning":{"publicId":"3225679","version":"1","preferredName":"FIGO Stage IA2","longName":"3225679","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is diagnosed microscopically only.  The stromal invasion is more than 3.00 mm but no more than 5.00 mm with a horizontal spread of 7.00 mm or less; there is no FIGO stage A2 for endometrial cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IA2","conceptCode":"C96247","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is diagnosed microscopically only.  The stromal invasion is more than 3.00 mm but no more than 5.00 mm with a horizontal spread of 7.00 mm or less; there is no FIGO stage A2 for endometrial cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-5124-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-513D-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IA1","valueDescription":"FIGO Stage IA1","ValueMeaning":{"publicId":"3225680","version":"1","preferredName":"FIGO Stage IA1","longName":"3225680","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is diagnosed microscopically only.  The stromal invasion has a maximum depth of 3.00 mm and a horizontal spread of 7.00 mm or less; there is no FIGO stage IA1 for endometrial cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IA1","conceptCode":"C96246","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is diagnosed microscopically only.  The stromal invasion has a maximum depth of 3.00 mm and a horizontal spread of 7.00 mm or less; there is no FIGO stage IA1 for endometrial cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-5149-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-5162-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IA","valueDescription":"FIGO Stage IA","ValueMeaning":{"publicId":"3225681","version":"1","preferredName":"FIGO Stage IA","longName":"3225681","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is diagnosed microscopically only.  The stromal invasion has a maximum depth of 5.00 mm and a horizontal spread of 7.00 mm or less; for endometrial cancer, it refers to cancer limited to endometrium or invades less than one-half of the myometrium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IA","conceptCode":"C96245","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is diagnosed microscopically only.  The stromal invasion has a maximum depth of 5.00 mm and a horizontal spread of 7.00 mm or less; for endometrial cancer, it refers to cancer limited to endometrium or invades less than one-half of the myometrium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-516E-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-5187-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage I","valueDescription":"FIGO Stage I","ValueMeaning":{"publicId":"3225682","version":"1","preferredName":"FIGO Stage I","longName":"3225682","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is confined to the cervix; for endometrial cancer, it refers to cancer confined to the corpus uteri with no or less than one-half myometrial invasion (IA) or invasion of one-half or more of the myometrium (IB).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage I","conceptCode":"C96244","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is confined to the cervix; for endometrial cancer, it refers to cancer confined to the corpus uteri with no or less than one-half myometrial invasion (IA) or invasion of one-half or more of the myometrium (IB).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-5193-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-51AC-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage 0","valueDescription":"FIGO Stage 0","ValueMeaning":{"publicId":"3225683","version":"1","preferredName":"FIGO Stage 0","longName":"3225683","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers and refers to carcinoma in situ.  For cervical cancer, it used to refer to cancer that is confined to the cervical epithelium without stromal invasion; for endometrial cancer, it used to refer to cancer that is confined to the endometrium without myometrial invasion.  FIGO no longer includes stage 0 cervical or endometrial cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage 0","conceptCode":"C96243","definition":"A FIGO stage term that applies to gynecologic cancers and refers to carcinoma in situ.  For cervical cancer, it used to refer to cancer that is confined to the cervical epithelium without stromal invasion; for endometrial cancer, it used to refer to cancer that is confined to the endometrium without myometrial invasion.  FIGO no longer includes stage 0 cervical or endometrial cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-51B8-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A0338BA5-51D1-7BC8-E040-BB89AD4341A0","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","deletedIndicator":"No"},{"value":"Stage IIA1","valueDescription":"Stage IIA1 Cervical Cancer","ValueMeaning":{"publicId":"3431288","version":"1","preferredName":"Stage IIA1 Cervical Cancer","longName":"3431288","preferredDefinition":"Stage IIA1 includes: T2a1, N0, M0.  Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion.  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA1 Cervical Cancer AJCC v7","conceptCode":"C95172","definition":"Stage IIA1 includes: T2a1, N0, M0.  Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion.  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-6628-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEB10F-E1EA-A584-E040-BB89AD433EC2","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"Stage IIA2","valueDescription":"Stage IIA2 Cervical Cancer","ValueMeaning":{"publicId":"3431287","version":"1","preferredName":"Stage IIA2 Cervical Cancer","longName":"3431287","preferredDefinition":"Stage IIA2 includes: T2a2, N0, M0.  Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA2 Cervical Cancer AJCC v7","conceptCode":"C95173","definition":"Stage IIA2 includes: T2a2, N0, M0.  Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-6603-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEB10F-E1FF-A584-E040-BB89AD433EC2","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3225661","version":"1","preferredName":"Gynecologic Neoplasm Federation of Gynecology and Obstetrics Stage","preferredDefinition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology.  They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C28016:C3262:C89808:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gynecologic","conceptCode":"C28016","definition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Federation of Gynecology and Obstetrics","conceptCode":"C89808","definition":"An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology. They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4EAB-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"ONEDATA","dateModified":"2011-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4EBC-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"COOPERM","dateModified":"2012-06-05","changeDescription":"Released per approval from T. Lichtenberg for TCGA. mc 4/7/11 Added 2 PVs per request by T.Lichtenberg. mc 4/25/12 Added 2009 to long name as part of CRF standard harmonization. mc 6/4/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3434438","version":"1","longName":"Cervical","context":"NCIP"},{"publicId":"3444894","version":"1","longName":"Corpus Uteri Carcinoma","context":"NCIP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000586","version":"1","longName":"FIGO","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000585","version":"1","longName":"FIGO","context":"NCI Standards"},{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"}],"ReferenceDocuments":[{"name":"FIGO Stage","type":"Preferred Question Text","description":"FIGO Stage","url":null,"context":"NCI Standards"},{"name":"TCGA Other Malignancy Question","type":"Application Standard Question Text","description":"FIGO Stage for the Other Malignancy","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"A0338BA5-51E1-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for TCGA by request of T.Lichtenberg. mc 4/5/2011 Added clarifiying terms to long name to match definition as part of CRF standard harmonization. mc 6/4/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}